All this is closely related to a higher number of patients with T2DM, metabolic syndrome and obesity, in addition to a higher genetic risk related mainly with the presence of polymorphism PNPLA3 (Patatin like phospholipase domain-containing protein 3). This evidence concerns the gene PNPLA3 and obesity due to melanocortin 4 receptor deficiency.